Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Mar-23 7:53 AM View:  | Zevra Therapeutics, Inc. (ZVRA) | 09-Mar-23 | Private Purchase | 10,000 | $4.20 | $41,978.00 | 50% 19.97K to 29.97K | |
| 13-Jan-23 5:27 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 13-Jan-23 | Private Purchase | 9,500 | $5.44 | $51,679.10 | 91% 10.47K to 19.97K | |
| 18-May-22 5:25 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 18-May-22 | Private Purchase | 5,000 | $4.92 | $24,607.60 | 152% 3.29K to 8.29K | |
| 30-Nov-21 7:42 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 30-Nov-21 | Market Purchase | 1,500 | $7.88 | $11,822.10 | 84% 1.78K to 3.29K | (< 1%) |
| 30-Mar-21 6:28 PM View: | Histogen Inc. (HSTO) | 30-Mar-21 | Market Purchase | 20,000 | $1.14 | $22,800.00 | 200% 10.0K to 30.0K | < 1% |
| 07-Dec-20 4:06 PM View: | Histogen Inc. (HSTO) | 03-Dec-20 | Market Purchase | 10,000 | $1.24 | $12,394.00 | 100% 0 to 10.0K | (3%) |
| 18-Aug-20 4:55 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 18-Aug-20 | Private Purchase | 10,000 | $0.64 | $6,351.80 | 54% 18.57K to 28.57K | |
| 02-Jul-19 5:03 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 30-Jun-19 | Grant | 8,928 | -- | -- | 93% 9.64K to 18.57K | |
| 14-May-19 8:39 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 10-May-19 | Grant | 9,645 | -- | -- | 100% 0 to 9.64K | |
| 24-Jan-19 6:05 AM View: | NexMed Inc. (SEEL) | 23-Jan-19 | Payment of Exercise | 44,810 | $0.23 | $10,149.50 | (22%) 200.21K to 155.4K | 38% |
| 30-Nov-18 7:37 PM View: | NexMed Inc. (SEEL) | 30-Nov-18 | Payment of Exercise | 17,290 | $0.31 | $5,290.74 | (8%) 217.5K to 200.21K | 57% |
| 03-Jan-18 7:45 PM View: | NexMed Inc. (SEEL) | 01-Jan-18 | Payment of Exercise | 7,679 | $1.84 | $14,129.40 | (3%) 225.18K to 217.5K | 94% |
| 07-Sep-17 4:09 PM View: | NexMed Inc. (SEEL) | 05-Sep-17 | Payment of Exercise | 18,790 | $1.56 | $29,312.40 | (8%) 243.97K to 225.18K | 93% |
| 05-Jun-17 4:10 PM View: | NexMed Inc. (SEEL) | 01-Jun-17 | Grant | 100,000 | -- | -- | 69% 143.97K to 243.97K | |
| 24-Mar-17 4:12 PM View: | NexMed Inc. (SEEL) | 15-Feb-17 | Payment of Exercise | 3,712 | $2.78 | $10,319.40 | (3%) 147.68K to 143.97K | 96% |
| 06-Jan-17 7:29 PM View: | NexMed Inc. (SEEL) | 05-Jan-17 | Grant | 100,000 | -- | -- | 210% 47.68K to 147.68K | |
| 27-Apr-16 7:59 PM View: | NexMed Inc. (SEEL) | 25-Apr-16 | Grant | 350,000 | -- | -- | 276% 126.78K to 476.78K | |
| 17-Mar-16 4:31 PM View: | NexMed Inc. (SEEL) | 15-Mar-16 | Grant | 79,778 | -- | -- | 170% 47.0K to 126.78K | |
| 22-Dec-14 4:32 PM View: | NexMed Inc. (SEEL) | 22-Dec-14 | Market Purchase | 10,000 | $1.02 | $10,217.00 | 27% 37.0K to 47.0K | (99%) |
| 24-Oct-14 2:41 PM View: | NexMed Inc. (SEEL) | 22-Oct-14 | Market Purchase | 12,000 | $1.51 | $18,120.00 | 48% 25.0K to 37.0K | (99%) |
| 10-Feb-14 4:10 PM View: | NexMed Inc. (SEEL) | 30-Dec-13 | Gift | 10,000 | -- | -- | (29%) 35.0K to 25.0K | |
| 24-May-13 4:49 PM View: | NexMed Inc. (SEEL) | 23-May-13 | Market Purchase | 35,000 | $2.85 | $99,750.00 | 100% 0 to 35.0K | (100%) |
| 08-Mar-13 1:25 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 06-Mar-13 | Disposition | 98,294 | -- | -- | (100%) 98.29K to 0 | |
| 03-Jan-13 6:53 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-12 | Grant | 7,142 | -- | -- | 7% 97.78K to 104.93K | |
| 20-Nov-12 1:58 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 16-Nov-12 | Grant | 50,000 | -- | -- | 93% 54.03K to 104.03K | |
| 02-Oct-12 9:18 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 30-Sep-12 | Grant | 75,119 | -- | -- | 24% 307.16K to 382.28K | |
| 03-Jul-12 4:52 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 02-Jul-12 | Grant | 76,437 | -- | -- | 33% 230.73K to 307.16K | |
| 04-Jan-12 1:58 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 03-Jan-12 | Market Sale (Planned) | 18,750 | $0.48 | $8,943.75 | (8%) 249.48K to 230.73K | 59% |
| 13-Jun-11 6:16 AM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 10-Jun-11 | Market Purchase | 11,100 | $2.25 | $24,942.80 | 6% 196.71K to 207.81K | (91%) |
| 09-Mar-11 5:31 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 07-Mar-11 | Grant | 125,000 | -- | -- | 174% 71.71K to 196.71K | |
| 03-Dec-10 5:55 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 01-Dec-10 | Market Sale (Planned) | 13,781 | $2.68 | $36,977.20 | (16%) 85.49K to 71.71K | 93% |
| 05-Apr-10 6:12 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 01-Apr-10 | Grant | 50,000 | -- | -- | 323% 15.49K to 65.49K | |
| 19-Mar-10 9:56 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 18-Mar-10 | Option Exercise | 100,000 | $1.23 | $123,000.00 | 500% 20.0K to 120.0K | |
| 19-Mar-10 9:56 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 18-Mar-10 | Market Option Sale | 100,000 | $5.96 | $596,406.00 | (83%) 120.0K to 20.0K | 97% |
| 19-Mar-10 9:56 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 18-Mar-10 | Market Sale (Planned) | 4,510 | $6.50 | $29,311.40 | (23%) 20.0K to 15.49K | 97% |
| 03-Mar-10 7:28 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 01-Mar-10 | Option Exercise | 40,000 | $1.23 | $49,200.00 | 100% 0 to 40.0K | |
| 03-Mar-10 7:28 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 01-Mar-10 | Market Option Sale (Planned) | 40,000 | $4.01 | $160,524.00 | (100%) 40.0K to 0 | 95% |
| 09-Feb-10 7:29 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 05-Feb-10 | Option Exercise | 50,000 | $1.23 | $61,500.00 | 417% 12.0K to 62.0K | |
| 09-Feb-10 7:29 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 05-Feb-10 | Market Option Sale (Planned) | 50,000 | $3.03 | $151,290.00 | (81%) 62.0K to 12.0K | 94% |
| 09-Feb-10 7:29 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 05-Feb-10 | Market Sale (Planned) | 12,000 | $3.03 | $36,309.60 | (100%) 12.0K to 0 | 94% |
| 05-Jan-10 5:30 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-09 | Market Sale (Planned) | 8,000 | $1.07 | $8,546.40 | (13%) 60.0K to 52.0K | 82% |
| 19-Feb-09 7:33 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 17-Feb-09 | Grant | 45,872 | -- | -- | 76% 60.0K to 105.87K | |
| 02-Dec-08 6:46 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 28-Nov-08 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K |